IL165333A0 - Probiotics and oral tolerance - Google Patents

Probiotics and oral tolerance

Info

Publication number
IL165333A0
IL165333A0 IL16533303A IL16533303A IL165333A0 IL 165333 A0 IL165333 A0 IL 165333A0 IL 16533303 A IL16533303 A IL 16533303A IL 16533303 A IL16533303 A IL 16533303A IL 165333 A0 IL165333 A0 IL 165333A0
Authority
IL
Israel
Prior art keywords
probiotics
oral tolerance
tolerance
oral
Prior art date
Application number
IL16533303A
Other languages
English (en)
Original Assignee
Nestec Sa
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Nestec Sa filed Critical Nestec Sa
Publication of IL165333A0 publication Critical patent/IL165333A0/xx

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/745—Bifidobacteria
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K10/00—Animal feeding-stuffs
    • A23K10/10—Animal feeding-stuffs obtained by microbiological or biochemical processes
    • A23K10/16—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions
    • A23K10/18—Addition of microorganisms or extracts thereof, e.g. single-cell proteins, to feeding-stuff compositions of live microorganisms
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23K—FODDER
    • A23K50/00—Feeding-stuffs specially adapted for particular animals
    • A23K50/40—Feeding-stuffs specially adapted for particular animals for carnivorous animals, e.g. cats or dogs
    • A—HUMAN NECESSITIES
    • A23—FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23L—FOODS, FOODSTUFFS, OR NON-ALCOHOLIC BEVERAGES, NOT COVERED BY SUBCLASSES A21D OR A23B-A23J; THEIR PREPARATION OR TREATMENT, e.g. COOKING, MODIFICATION OF NUTRITIVE QUALITIES, PHYSICAL TREATMENT; PRESERVATION OF FOODS OR FOODSTUFFS, IN GENERAL
    • A23L29/00—Foods or foodstuffs containing additives; Preparation or treatment thereof
    • A23L29/065—Microorganisms
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A61K35/744—Lactic acid bacteria, e.g. enterococci, pediococci, lactococci, streptococci or leuconostocs
    • A61K35/747—Lactobacilli, e.g. L. acidophilus or L. brevis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/02—Immunomodulators
    • A61P37/06—Immunosuppressants, e.g. drugs for graft rejection
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Microbiology (AREA)
  • Engineering & Computer Science (AREA)
  • Polymers & Plastics (AREA)
  • Mycology (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Food Science & Technology (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Molecular Biology (AREA)
  • Zoology (AREA)
  • Animal Husbandry (AREA)
  • Epidemiology (AREA)
  • Immunology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nutrition Science (AREA)
  • General Chemical & Material Sciences (AREA)
  • Biotechnology (AREA)
  • Biochemistry (AREA)
  • Biomedical Technology (AREA)
  • Physiology (AREA)
  • Birds (AREA)
  • Transplantation (AREA)
  • Pulmonology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Coloring Foods And Improving Nutritive Qualities (AREA)
  • Fodder In General (AREA)
  • Dairy Products (AREA)
IL16533303A 2002-05-24 2003-05-22 Probiotics and oral tolerance IL165333A0 (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
EP02011444A EP1364586A1 (en) 2002-05-24 2002-05-24 Probiotics and oral tolerance
PCT/EP2003/005354 WO2003099037A1 (en) 2002-05-24 2003-05-22 Probiotics and oral tolerance

Publications (1)

Publication Number Publication Date
IL165333A0 true IL165333A0 (en) 2006-01-15

Family

ID=29286151

Family Applications (1)

Application Number Title Priority Date Filing Date
IL16533303A IL165333A0 (en) 2002-05-24 2003-05-22 Probiotics and oral tolerance

Country Status (14)

Country Link
US (1) US20050180961A1 (no)
EP (2) EP1364586A1 (no)
JP (1) JP2005538703A (no)
KR (1) KR20050004223A (no)
CN (1) CN1662154A (no)
AU (1) AU2003242557A1 (no)
BR (1) BR0311281A (no)
CA (1) CA2487021A1 (no)
IL (1) IL165333A0 (no)
MX (1) MXPA04011664A (no)
NO (1) NO20045588L (no)
RU (1) RU2004137806A (no)
WO (1) WO2003099037A1 (no)
ZA (1) ZA200410399B (no)

Families Citing this family (59)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
EP1110555A1 (fr) 1999-12-22 2001-06-27 Societe Des Produits Nestle S.A. Agent anti-adhesion de la flore pathogene de la peau
EP1478242B1 (en) * 2002-02-21 2014-04-30 Societe Des Produits Nestle S.A. Pet food composition for skin photoprotection
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance
CN1767839B (zh) * 2003-03-13 2012-08-22 麒麟控股株式会社 抗过敏的组合物
US8877178B2 (en) 2003-12-19 2014-11-04 The Iams Company Methods of use of probiotic bifidobacteria for companion animals
US20050158294A1 (en) 2003-12-19 2005-07-21 The Procter & Gamble Company Canine probiotic Bifidobacteria pseudolongum
MXPA06015184A (es) 2004-06-23 2007-11-22 Nestec Sa Procedimiento y composiciones utiles para prevenir y/o tratar pieles sensibles y/o secas.
US7862808B2 (en) 2004-07-01 2011-01-04 Mead Johnson Nutrition Company Method for preventing or treating respiratory infections and acute otitis media in infants using Lactobacillus rhamnosus LGG and Bifidobacterium lactis Bb-12
EP1731137A1 (fr) * 2005-06-08 2006-12-13 Nestec S.A. Composition cosmétique ou dermatologique pour peaux sèches et/ou sensibles
WO2006037922A1 (fr) * 2004-10-04 2006-04-13 L'oreal Composition cosmetique et/ou dermatologique pour peaux sensibles
EP1642570A1 (fr) 2004-10-04 2006-04-05 L'oreal Composition cosmétique et/ou dermatologique pour peaux sensibles
RU2270248C1 (ru) * 2004-12-31 2006-02-20 Открытое акционерное общество "Лианозовский молочный комбинат" Штамм бифидобактерий bifidobacterium lactis 668, используемый для приготовления кисломолочных, ферментированных и неферментированных пищевых продуктов, биологически активных добавок, бактериальных препаратов и косметических средств
ES2524344T3 (es) * 2005-02-28 2014-12-05 N.V. Nutricia Composición nutritiva con probióticos
US20060233762A1 (en) * 2005-04-15 2006-10-19 Mcmahon Robert J Method for treating or preventing systemic inflammation in formula-fed infants
US7303745B2 (en) 2005-04-15 2007-12-04 Bristol-Myers Squibb Company Method for preventing or treating the development of respiratory allergies
EP1724340B1 (en) * 2005-05-11 2009-02-18 Chr. Hansen A/S Antibiotic-sensitive lactic acid bacteria strains
US8021883B2 (en) 2005-05-11 2011-09-20 Chr. Hansen A/S Antibiotic-sensitive lactic acid bacteria strains
AR052472A1 (es) * 2005-05-31 2007-03-21 Iams Company Lactobacilos probioticos para felinos
CA2607949C (en) * 2005-05-31 2012-09-25 Thomas William-Maxwell Boileau Feline probiotic bifidobacteria
FR2889057B1 (fr) * 2005-08-01 2008-07-18 Oreal Composition cosmetique et/ou dermatologique pour la prevention et/ou le traitement des peaux sensibles ou seches
WO2007039313A2 (en) * 2005-10-06 2007-04-12 Nestec S.A. Probiotic enterococci for improved immunity
EP1776877A1 (en) 2005-10-21 2007-04-25 N.V. Nutricia Method for stimulating the intestinal flora
AU2006313660B2 (en) 2005-11-14 2012-07-19 Nestec S.A. Oral tolerance promotion with glycated proteins
JP5410759B2 (ja) 2005-11-29 2014-02-05 アクトジェニックス・エヌブイ 抗原に対する粘膜寛容の誘導
NL1032840C2 (nl) * 2006-11-09 2008-05-13 Friesland Brands Bv Probiotische hydrolysaatvoeding voor kinderen.
US8226936B2 (en) 2006-11-15 2012-07-24 Chr-Hansen A/S Tetracycline-sensitive bifidobacteria strains
EP2125010B1 (en) 2007-01-25 2014-06-04 Actogenix N.V. Treatment of immune disease by mucosal delivery of antigens using genetically modified lactobacillus
AU2008211600B8 (en) 2007-02-01 2014-02-13 Mars, Incorporated Method for decreasing inflammation and stress in a mammal using glucose antimetabolites, avocado or avocado extracts
MX2009008875A (es) * 2007-02-28 2009-08-28 Mead Johnson Nutrition Co Producto que contiene probiotico inactivado para niños o infantes.
FR2919501B1 (fr) * 2007-08-02 2010-12-31 Oreal Utilisation d'hesperidine ou de l'un de ses derives pour la prevention et/ou le traitement des peaux relachees
FR2920305B1 (fr) 2007-09-04 2010-07-30 Oreal Utilisation d'un lysat de bifidobacterium species pour le traitement de peaux sensibles.
CN101815502B (zh) * 2007-09-04 2013-10-09 欧莱雅 橙皮苷和微生物的组合在影响皮肤的屏障功能中的用途
FR2920304B1 (fr) * 2007-09-04 2010-06-25 Oreal Utilisation cosmetique de lysat bifidobacterium species pour le traitement de la secheresse.
ES2585407T3 (es) * 2008-02-01 2016-10-05 Murdoch Childrens Research Institute Un método para inducir tolerancia a un alérgeno
US9771199B2 (en) 2008-07-07 2017-09-26 Mars, Incorporated Probiotic supplement, process for making, and packaging
DK2285387T3 (en) * 2008-06-13 2016-01-25 Nutricia Nv Nutrition for preventing infections
WO2009151315A1 (en) * 2008-06-13 2009-12-17 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
WO2010002241A1 (en) * 2008-06-30 2010-01-07 N.V. Nutricia Nutritional composition for infants delivered via caesarean section
US9232813B2 (en) * 2008-07-07 2016-01-12 The Iams Company Probiotic supplement, process for making, and packaging
CN101768559B (zh) * 2008-12-31 2012-03-07 生展生物科技股份有限公司 副干酪乳杆菌副干酪亚种菌株及其抑菌组合物和用途
FR2942719B1 (fr) 2009-03-04 2011-08-19 Oreal Utilisation de microorganismes probiotiques pour limiter les irritations cutanees
CA2761444C (en) * 2009-05-11 2018-04-24 Nestec S.A. Lactobacillus johnsonii la1 ncc533 (cncm i-1225) and immune disorders
US10104903B2 (en) 2009-07-31 2018-10-23 Mars, Incorporated Animal food and its appearance
EP2332557A1 (en) 2009-12-08 2011-06-15 Campina Nederland Holding B.V. Probiotic lactic acid bacteria
CA2805500C (en) * 2010-08-03 2015-01-27 Hill's Pet Nutrition, Inc. Pet food compositions having antimicrobial activity
EE05750B1 (et) 2011-02-25 2015-06-15 OÜ Tervisliku Piima Biotehnoloogiate Arenduskeskus Isoleeritud mikroorganismi tüvi Lactobacillus gasseri MCC2 DSM 23882 ning selle kasutamine
EP2510932A1 (en) * 2011-04-15 2012-10-17 Nestec S.A. Lactobacillus paracasei NCC2461 (ST11) for use by perinatal maternal administration in the reduction and prevention of allergies in progeny
CN103997899B (zh) * 2011-06-20 2016-04-20 H.J.亨氏公司 益生菌组合物和方法
BR112014000322A2 (pt) * 2011-07-12 2017-01-10 Nestec Sa "probióticos, e seus usos"
WO2013187755A1 (en) 2012-06-14 2013-12-19 N.V. Nutricia Fermented infant formula with non digestible oligosaccharides
RU2654705C2 (ru) 2012-06-18 2018-05-22 Г.Дж. Хайнц Компани Брэндс ЛЛК Глютенозависимые расстройства
BR112015028164B1 (pt) 2013-05-10 2022-02-08 H.J. Heinz Company Brands Llc Usos da bactéria probiótica, lactobacillus paracasei, para tratar uma infecção microbiana e para prevenir ou reduzir a gravidade de uma infecção microbiana
JP6590330B2 (ja) * 2013-11-11 2019-10-16 キッコーマン株式会社 経口免疫寛容増強物質のスクリーニング方法および経口免疫寛容増強組成物
MA41020A (fr) 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
WO2016148562A1 (en) 2015-03-18 2016-09-22 N.V. Nutricia Method for inducing oral tolerance via administration of beta-lactoglobulin derived peptide in combination with probiotic
WO2017109735A1 (en) * 2015-12-22 2017-06-29 Nestec Sa Oral health for companion animals
JP6408092B2 (ja) * 2016-08-29 2018-10-17 国立大学法人 東京大学 糞便微生物叢を含む組成物
JP2020000033A (ja) * 2018-06-26 2020-01-09 国立大学法人広島大学 経口免疫寛容誘導剤、これを含有する食品および医薬品、ならびに加工食品の製造方法
WO2024042229A1 (en) 2022-08-25 2024-02-29 Chr. Hansen A/S Bifidobacterium strains with improved stability

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FI104465B (fi) * 1995-06-14 2000-02-15 Valio Oy Proteiinihydrolysaatteja allergioiden hoitamiseksi tai estämiseksi, niiden valmistus ja käyttö
JPH10309178A (ja) * 1997-05-09 1998-11-24 Wakamoto Pharmaceut Co Ltd ビフィズス菌を有効成分とする抗アレルギー剤および醗酵食品
EP0904784A1 (en) * 1997-09-22 1999-03-31 N.V. Nutricia Probiotic nutritional preparation
SE510813C2 (sv) * 1997-12-08 1999-06-28 Arla Ekonomisk Foerening Bakteriestam av arten Lactobacillus Paracasei subsp. paracasei, sammansättning därav för användning i livsmedel, samt produkt innehållande stammen
EP1251747B1 (en) * 2000-01-18 2012-01-25 Société des Produits Nestlé S.A. Pet food composition for treating helicobacter species in pets
JP2001231495A (ja) * 2000-02-18 2001-08-28 Nichinichi Seiyaku Kk 好酸球集積抑制作用を有する食品
FI110668B (fi) * 2000-06-20 2003-03-14 Aboatech Ab Oy Probioottien käyttö atooppisten sairauksien primaariseen ehkäisyyn
EP1364586A1 (en) * 2002-05-24 2003-11-26 Nestec S.A. Probiotics and oral tolerance

Also Published As

Publication number Publication date
MXPA04011664A (es) 2005-03-07
CN1662154A (zh) 2005-08-31
US20050180961A1 (en) 2005-08-18
EP1364586A1 (en) 2003-11-26
ZA200410399B (en) 2006-02-22
NO20045588L (no) 2005-02-23
EP1511394A1 (en) 2005-03-09
WO2003099037A1 (en) 2003-12-04
CA2487021A1 (en) 2003-12-04
BR0311281A (pt) 2005-03-29
JP2005538703A (ja) 2005-12-22
AU2003242557A1 (en) 2003-12-12
KR20050004223A (ko) 2005-01-12
RU2004137806A (ru) 2005-08-20

Similar Documents

Publication Publication Date Title
IL165333A0 (en) Probiotics and oral tolerance
EP1539941A4 (en) ADZYMES AND THEIR USES
AU2003272187A8 (en) Novel nanoparticles and use thereof
GB0209668D0 (en) Oral devices
IL163868A0 (en) Hermiasterlin derivatives and uses thereof
AU2003296369A8 (en) Imminoamines and preparation thereof
GB0428391D0 (en) Connection and connection part
GB0220214D0 (en) Compounds and their use
SI1551805T1 (sl) Substituirani gama-fenil-delta-laktami in njihova uporaba
AU2003298129A8 (en) Floor-furnace chimney and the use thereof
IL165112A0 (en) Variant integrinpolypeptides and thereof
AU2003267361A8 (en) Orthopoxvirus antigens and use thereof
AU2003231827A8 (en) Pseudo-tissues and uses thereof
AU2003284942A8 (en) Oral extended release tablets and methods of making and using the same
AU2003302173A8 (en) Spirotetrathiocarbamates and spirooxothiocarbamates
AU2003286392A8 (en) 1microarrays and production thereof
GB0207624D0 (en) Chemokine and uses thereof
AU2003228397A8 (en) Hausp-p53 interaction and uses thereof
AU2003216442A8 (en) Enkurin and uses thereof
EP1499338A4 (en) 7-HYDROXY-16ALPHA-FLUORO-5-ANDROSENES-17-ONE AND 7-HYDROXY-16ALPHA-FLUORO-5-ANDROSTAN-17-ONE AND THEIR DERIVATIVES
GB0218031D0 (en) Compounds and their use
GB0209377D0 (en) Oral formulations and uses
GB0223293D0 (en) Arch - 1 and half; arch - 3
GB0220215D0 (en) Compounds and their use
PL354667A1 (en) Probiotic preparation